glp 1 agonist therapy GLP-1 Receptor Agonists: The New Wave in Diabetes Management Gastrointestinal effect and adverse effects

Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, et al

FOR DECREASED APPETITE SOURCE: DailyMed

When one drug inhibits CYP enzymes responsible for metabolising another CNS drug, plasma and brain concentrations may rise, increasing the risk of toxicity

Consistent with these data, central administration of the GLP-1R agonists liraglutide and exendin-4 increases energy expenditure and BAT thermogenesis through mechanisms that include AMPK signaling in the mediobasal hypothalamus [666]

GLP-1 RAs can be classified according to their structure, duration of action and mode of administration

Market Share : North America and Europe collectively hold more than 70% of the market share, with the US holding the lions share